GlassScriptPhysician profile
James P Crutcher
NPI 1881663292
$3,455,841.40
in general payments reported to CMS, 2019-2025
13 companies · $157K in 2025
The $157K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603K · 2020: $623K · 2021: $707K · 2022: $770K · 2023: $323K · 2024: $272K · 2025: $157K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $479K · Royalty Or License: $197K · Travel and Lodging: $68K · Food and Beverage: $7,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $478,818.75 |
| Royalty Or License | $197,486.22 |
| Travel and Lodging | $67,512.14 |
| Food and Beverage | $7,775.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,452,250.94 | 2019-2025 | Mako, Triathlon, Insignia |
| Medacta USA, INC. | $1,036.97 | 2020 | |
| Smith+Nephew, INC. | $515.66 | 2019-2023 | Evos |
| Zimmer Biomet Holdings, INC. | $441.53 | 2019-2021 | |
| Avanos Medical | $440.63 | 2022-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Orthalign INC | $351.36 | 2024 | Orthalign Plus |
| Davol INC. | $267.39 | 2025 | |
| Heron Therapeutics, INC. | $210.29 | 2022-2023 | Zynrelef |
| Omnilife Science, INC | $172.58 | 2024 | Apollo Knee (Fka Omnibotics 3.0) |
| Depuy Synthes Sales INC. | $84.84 | 2021 | |
| Orthosensor INC. | $34.96 | 2019 | |
| Medical Device Business Services, INC. | $20.05 | 2021 | |
| Ethicon US, LLC | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Crutcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.